Title: Real-World Evidence on the Effectiveness and Safety of Tofacitinib in Patients with
Ulcerative Colitis in Lebanon
Version: 3 Date: 26 Jan 2024
Reviewer's report:
The language is simple and well-formed.
The introduction is informative and well-referenced.
Such a study is informative and valuable, especially in the Middle East. However, the sample
size is small, and a larger sample is needed to evaluate the effectiveness of this therapy and to
make a comparison to the larger meta-analysis more justified and logical.
Even if a consent form is not needed in the study, I think that this study needs ethical approval.
I recommend that there should be a scale about the degree of satisfaction patients have with
their experience and, if applicable, a sentence about the cost of therapy and comparison to other
modalities, as this is very important in an area like the Middle East.
Title: Real-World Evidence on the Effectiveness and Safety of Tofacitinib in Patients with
Ulcerative Colitis in Lebanon
Version: 3 Date: 26 Jan 2024
Reviewer's report:
The language is simple and well-formed.
The introduction is informative and well-referenced.
Such a study is informative and valuable, especially in the Middle East. However, the sample
size is small, and a larger sample is needed to evaluate the effectiveness of this therapy and to
make a comparison to the larger meta-analysis more justified and logical.
Even if a consent form is not needed in the study, I think that this study needs ethical approval.
I recommend that there should be a scale about the degree of satisfaction patients have with
their experience and, if applicable, a sentence about the cost of therapy and comparison to other
modalities, as this is very important in an area like the Middle East.
Please review this paper.
user
Title: Real-World Evidence on the Effectiveness and Safety of Tofacitinib in Patients with
Ulcerative Colitis in Lebanon
Version: 3 Date: 26 Jan 2024
Reviewer's report:
The language is simple and well-formed.
The introduction is informative and well-referenced.
Such a study is informative and valuable, especially in the Middle East. However, the sample
size is small, and a larger sample is needed to evaluate the effectiveness of this therapy and to
make a comparison to the larger meta-analysis more justified and logical.
Even if a consent form is not needed in the study, I think that this study needs ethical approval.
I recommend that there should be a scale about the degree of satisfaction patients have with
their experience and, if applicable, a sentence about the cost of therapy and comparison to other
modalities, as this is very important in an area like the Middle East.
assistant